The asthma mortality rate for women in the US is forecasted to remain stable at 1.3 deaths per 100,000 from 2024 to 2028. In 2023, this rate was similarly recorded at 1.3, reflecting no variation in the year-on-year comparison. Over the last five years, the compound annual growth rate (CAGR) also shows no change, as the value has consistently remained at 1.3.

Future trends to watch for include:

The impact of healthcare policy changes on asthma management and mortality rates.
Advancements in treatment options and their adoption rates among women.
Public health initiatives aimed at reducing environmental triggers contributing to asthma exacerbations.